You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic eosinophilic leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022

BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

Recruiting
  • BCR-JAK2 Fusion Protein Expression
  • +11 more
  • Palo Alto, California
  • +3 more
Oct 5, 2022

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • +2 more
  • Mepolizumab 100 MG
  • Athens, Attiki, Greece
  • +1 more
Sep 29, 2023

Endoscopic Frontal Sinus Surgery, Chronic Rhinosinusitis With Nasal Polyps, Draf III Trial in Tanta (Endoscopic frontal sinus

Recruiting
  • Endoscopic Frontal Sinus Surgery
  • +3 more
  • Endoscopic frontal sinus surgery grade 6(Draf III).
  • Endoscopic frontal sinus surgery grade 1-3(Draf I or IIa)
  • Tanta, El-Gharbia, Egypt
  • +1 more
Jul 29, 2023

Chronic Rhinosinusitis (Diagnosis) Trial in Darlinghurst (Betamethasone Dipropionate Nasal Cream 0.0644%, Pre-filled syringe and

Recruiting
  • Chronic Rhinosinusitis (Diagnosis)
  • Betamethasone Dipropionate Nasal Cream 0.0644%
  • Pre-filled syringe and applicator device
  • Darlinghurst, New South Wales, Australia
    Sydney Ear Nose and Throat Clinic Pty Ltd
Sep 19, 2022

Adrenal Insufficiency in Eosinophilic Esophagitis on Chronic

Recruiting
  • Eosinophilic Esophagitis
  • Cortisol level
  • Aurora, Colorado
    University of Colorado Anschutz
Aug 12, 2022

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Loncastuximab Tesirine
    • (no location specified)
    Jul 24, 2023

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +46 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 10, 2021

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

    Not yet recruiting
    • Relapsed/Refractory Chronic Lymphocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Jul 13, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

    Recruiting
    • Myelodysplastic Syndromes
    • Chronic Myelomonocytic Leukemia
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Jul 30, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Chronic Cough, Eosinophilic Bronchitis, Asthma Trial in Hamilton (Mepolizumab, Normal Saline)

    Recruiting
    • Chronic Cough
    • +2 more
    • Hamilton, Ontario, Canada
      McMaster University
    Dec 16, 2021

    Rhinosinusitis Chronic Trial in Sao Paulo (Corticosteroid Topical, Placebo)

    Recruiting
    • Rhinosinusitis Chronic
    • Corticosteroid Topical
    • Placebo
    • Sao Paulo, SP, Brazil
      Luiz Eduardo Flório Junior
    Jul 4, 2022

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023